Basic Information
| LncRNA/CircRNA Name | LINC00982 |
| Synonyms | NA |
| Region | GRCh38_1:3059615-3068437 |
| Ensemble | ENSG00000177133 |
| Refseq | NR_015440 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | renal cancer |
| ICD-0-3 | C64.9 |
| Methods | qPCR, Western blot |
| Sample | renal cancer tissues and cell lines |
| Expression Pattern | down-regulated |
| Function Description | Downregulated LINC00982 expression was significantly observed in cancer samples when compared with the adjacent specimens, and was related to tumor size and TNM stage. |
| Pubmed ID | 30840265 |
| Year | 2019 |
| Title | Upregulation of LINC00982 inhibits cell proliferation and promotes cell apoptosis by regulating the activity of PI3K/AKT signaling pathway in renal cancer. |
External Links
| Links for LINC00982 | GenBank HGNC NONCODE |
| Links for renal cancer | OMIM COSMIC |